feed,title,long_url,short_url
Benzinga,"Regeneron's Skin Drugs Propel Revenue In Q3, Witnesses Strong Demand For Higher Dose Version Of Flagship Eye Drug",https://benzinga.com/general/biotech/23/11/35569003/regenerons-skin-drugs-propel-revenue-in-q3-witnesses-strong-demand-for-higher-dose-version-of-fla,https://da.gd/SgUv
